Delayed improvement in valve hemodynamic performance after percutaneous pulmonary valve implantation

Québec Heart Institute-Laval Hospital, Québec City, Québec, Canada.
The Annals of thoracic surgery (Impact Factor: 3.65). 06/2008; 85(5):1787-8. DOI: 10.1016/j.athoracsur.2007.11.007
Source: PubMed

ABSTRACT We report the case of a 21-year-old woman with a severely stenotic pulmonary homograft who underwent percutaneous pulmonary valve implantation, with no significant change in transvalvular gradient within the 24 hours after the procedure. Major improvement in hemodynamic valve performance of more than 60% decrease in transvalvular gradient and more than 30% increase in pulmonary valve area was observed 3 months after the procedure, showing that hemodynamic improvement can occur late after pulmonary valve implantation. An echocardiogram after 3 months should be done before concluding the procedure failed and that reintervention is necessary.


Available from: Jean Perron, Mar 30, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Here we report on the implementation of a new portable electronic nose instrument, inspired by the human olfactory system. Our ‘Portable e-Mucosa’ (PeM) utilizes three large sensor arrays consisting of 200 chemoresistive sensors per array, combined with two columns coated with differently retentive layers. This combination provides spatio-temporal information, mimicking the biological ‘nasal chromatograph’ effect[1]. These have been integrated with control electronics, a pre-concentrator, temperature control and a sample delivery system to produce a fully functional electronic nose (e-nose) instrument. Data from this device, when used with a pattern recognition method that utilizes temporal information and the large data set, we believe improves the discrimination power of this instrument over conventional e-noses.
    09/2009; 1(1):991-994. DOI:10.1016/j.proche.2009.07.247
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The fields of pediatric cardiology and congenital heart disease have experienced considerable progress in the last few years, with advances in new diagnostic and therapeutic techniques that can be applied at all stages of life from the fetus to the adult. This article reviews scientific publications in a number of areas that appeared between August 2007 and September 2008. In developed countries, congenital heart disease is becoming increasingly prevalent in nonpediatric patients, including pregnant women. Actions aimed at preventing coronary heart disease must be started early in infancy and should involve the promotion of a healthy diet and lifestyle. Recent developments in echocardiography include the introduction of three-dimensional echocardiography and of new techniques such as two-dimensional speckle tracking imaging, which can be used for both anatomical and functional investigations in patients with complex heart disease, including a univentricular heart. Progress has also occurred in fetal cardiology, with new data on prognosis and prognostic factors and developments in intrauterine interventions, though indications for these interventions have still to be established. Heart transplantation has become a routine procedure, supplemented in some cases by circulatory support devices. In catheter interventions, new devices have become available for the closure of atrial or ventricular septal defects and patent ductus arteriosus as well as for percutaneous pulmonary valve implantation. Surgery is also advancing, in some cases with hybrid techniques, particularly for the treatment of hypoplastic left heart syndrome. The article ends with a review of publications on cardiomyopathy, myocarditis and the treatment of bacterial endocarditis.
    Revista Espa de Cardiologia 01/2009; 9(1):39-52. DOI:10.1016/S1131-3587(09)71771-6 · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: As increasing numbers of patients with congenital heart disease enter adulthood, there is a growing need for minimally invasive percutaneous interventions, primarily to minimize the number of repeated surgeries required by these patients. The use of percutaneous devices is commonplace for the treatment of simple lesions, such as atrial septal defect, patent foramen ovale, patent duct arteriosus, and abnormal vascular connections. There is also substantial experience with device closure of membranous and muscular ventricular septal defects, as well as more complex shunts such as baffle leaks after atrial switch repair and ventricular pseudoaneurysms. An increasing use of covered stents has improved the safety of aortic coarctation, conduit, and branch pulmonary stenosis interventions. Percutaneous pulmonary valve implantation now has an established role in the setting of dysfunctional right ventricle-pulmonary artery conduits or failing bioprosthetic pulmonary valves. Many patients remain unsuitable for percutaneous pulmonary valve implantation because of large diameter "native" outflow tracts, however, various techniques have emerged and multiple devices are in development to provide solutions for these unique anatomic challenges. Hybrid approaches involving use of surgical and transcatheter techniques are increasingly common, serving to optimize efficacy and safety of certain procedures; they depend on a collaborative and collegial relationship between cardiac surgeons and interventionalists that is primarily patient-centred.
    The Canadian journal of cardiology 01/2014; 30(1):75-86. DOI:10.1016/j.cjca.2013.11.006 · 3.94 Impact Factor